These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19521997)

  • 1. Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains.
    Wei T; Gong J; Jamitzky F; Heckl WM; Stark RW; Rössle SC
    Protein Sci; 2009 Aug; 18(8):1684-91. PubMed ID: 19521997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9.
    Wang J; Shao Y; Bennett TA; Shankar RA; Wightman PD; Reddy LG
    J Biol Chem; 2006 Dec; 281(49):37427-34. PubMed ID: 17040905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9.
    Bauer S; Pigisch S; Hangel D; Kaufmann A; Hamm S
    Immunobiology; 2008; 213(3-4):315-28. PubMed ID: 18406377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains.
    Wei T; Gong J; Rössle SC; Jamitzky F; Heckl WM; Stark RW
    J Mol Model; 2011 Jan; 17(1):27-36. PubMed ID: 20352268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomal localization of TLR8 confers distinctive proteolytic processing on human myeloid cells.
    Ishii N; Funami K; Tatematsu M; Seya T; Matsumoto M
    J Immunol; 2014 Nov; 193(10):5118-28. PubMed ID: 25297876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling.
    Gibbard RJ; Morley PJ; Gay NJ
    J Biol Chem; 2006 Sep; 281(37):27503-11. PubMed ID: 16857668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
    Saitoh S; Miyake K
    Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of species-specific ligand recognition in Toll-like receptor 8 signaling: a hypothesis.
    Govindaraj RG; Manavalan B; Basith S; Choi S
    PLoS One; 2011; 6(9):e25118. PubMed ID: 21949866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.
    Ewald SE; Lee BL; Lau L; Wickliffe KE; Shi GP; Chapman HA; Barton GM
    Nature; 2008 Dec; 456(7222):658-62. PubMed ID: 18820679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands.
    Zhang Z; Ohto U; Shibata T; Taoka M; Yamauchi Y; Sato R; Shukla NM; David SA; Isobe T; Miyake K; Shimizu T
    Cell Rep; 2018 Dec; 25(12):3371-3381.e5. PubMed ID: 30566863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and expression analysis of toll-like receptor genes (TLR7, TLR8 and TLR9) of golden pompano (Trachinotus ovatus).
    Wei Y; Hu S; Sun B; Zhang Q; Qiao G; Wang Z; Shao R; Huang G; Qi Z
    Fish Shellfish Immunol; 2017 Apr; 63():270-276. PubMed ID: 28232281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations.
    Gentile F; Deriu MA; Licandro G; Prunotto A; Danani A; Tuszynski JA
    Molecules; 2015 May; 20(5):8316-40. PubMed ID: 26007168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
    Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
    J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
    Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
    J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements.
    Nishiya T; Kajita E; Miwa S; Defranco AL
    J Biol Chem; 2005 Nov; 280(44):37107-17. PubMed ID: 16105838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the C-terminal domain of mouse TLR9.
    Collins B; Wilson IA
    Proteins; 2014 Oct; 82(10):2874-8. PubMed ID: 24888966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
    Mishra BB; Mishra PK; Teale JM
    J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9.
    Heinz LX; Lee J; Kapoor U; Kartnig F; Sedlyarov V; Papakostas K; César-Razquin A; Essletzbichler P; Goldmann U; Stefanovic A; Bigenzahn JW; Scorzoni S; Pizzagalli MD; Bensimon A; Müller AC; King FJ; Li J; Girardi E; Mbow ML; Whitehurst CE; Rebsamen M; Superti-Furga G
    Nature; 2020 May; 581(7808):316-322. PubMed ID: 32433612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ovine TLR7 and TLR8 protein coding regions, detection of mutations and Maedi Visna virus infection.
    Mikula I; Bhide M; Pastorekova S; Mikula I
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):51-9. PubMed ID: 20638136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.